Periodontal Assessment of a Bariatric Care Population
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorQueen Mary University of London
About this trial
Our primary aim is to investigate the prevalence and severity of Periodonotal Disease (PD) in a population of obese patients.
Our secondary objectives are to:
Investigate inflammatory biomarkers that have been associated with PD in the saliva of obese patients.
Investigate the association of FTO gene (Obesity) polymorphisms with the prevalence of PD in this population.
Investigate and describe the subgingival microbial flora in obese patients with PD from subgingival dental plaque samples as well as the salivary samples.
Eligibility criteria
Qualifiers
Subject must be over 18 years of age.
Subject must have a BMI of higher or equal to 30 kg/ m2
Subject must have voluntarily given written informed consent.
Disqualifiers
Subject is currently involved in other research involving the use of antibiotics or novel or unknown medications.
Self-reported pregnancy.
Subject is on chronic treatment (i.e., two weeks or more) with specific medications known to affect periodontal status (phenytoin or cyclosporine) within one month of baseline visit.
Subject knowingly has HIV or Viral Hepatitis.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Queen Mary University of London
Lead sponsor
University College London Hospitals
Collaborator
Source ClinicalTrials.gov